Home » Newsletters » BioWorld Science

BioWorld Science

July 20, 2006

View Archived Issues

MPC-7869 studied for drug interaction potential, efficacy in Alzheimer's disease

MK-677 does not affect Alzheimer's disease progression

Sipuleucel-T improves survival in hormone refractory prostate cancer

Acenta and PsychoGenics form psychiatric and neurological disorders collaboration

Alnylam and Inex advance collaboration on systemic delivery of RNAi therapeutics

Alnylam and UT Southwestern to develop RNAi therapeutics for high cholesterol

Transition Therapeutics and Novo Nordisk amend I.N.T. license agreement

Rivastigmine transdermal patch compares well with capsules

Tigris licenses anticancer compound from NIH

Astellas discontinues development of FK-962 for Alzheimer's disease

Cangene's NDA for rhGH Accretropin accepted for review

AstraZeneca files NDA for Seroquel SR

Topical antiinfective REP-8839 begins phase I testing

Starpharma cleared to study SPL-7013 gel for genital herpes prevention

Roche exercises option to Ipsen's antidiabetic drug BIM-51077

U.K. clearance for phase II study of Reolysin with low-dose radiation

Expanded multiple dose phase I trial of CG-0070 in recurrent bladder cancer

Theravance and Astellas add Japan to telavancin collaboration

Mycophenolate mofetil approved in Malaysia for lupus nephritis

Solvay seeks E.U. approval of Synordia

Frova filed for prevention of menstrual migraine

Calpain inhibitor and antioxidant BN-82270 protects from and helps recover hearing loss

First U.S. clinical data on huperzine A, a Chinese herbal medicine for AD

Promising preclinical data on novel classes of compounds developed at Enkam

Recent patents disclose novel antiinfective agents

Recent ViroChem patent reports novel HIV integrase inhibitors

Recent Novartis and Devgen patents describe new treatments for cardiovascular diseases

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...